Unfractionated Heparin: Multitargeted Therapy for Delayed Neurological Deficits Induced by Subarachnoid Hemorrhage
- 31 August 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neurocritical Care
- Vol. 13 (3), 439-449
- https://doi.org/10.1007/s12028-010-9435-1
Abstract
Aneurysmal subarachnoid hemorrhage (SAH) is associated with numerous “delayed neurological deficits” (DNDs) that have been attributed to multiple pathophysiological mechanisms, including ischemia, microthrombosis, free radical damage, inflammation, and vascular remodeling. To date, effective prophylactic therapy for SAH-induced DNDs has been elusive, due perhaps to the multiplicity of mechanisms involved that render typical, single-agent therapy seemingly futile. We hypothesized that heparin, which has multiple underappreciated salutary effects, might be useful as a multitargeted prophylactic agent against SAH-induced DNDs. We performed a comprehensive review of the literature to evaluate the potential utility of heparin in targeting the multiple pathophysiological mechanisms that have been identified as contributing to SAH-induced DNDs. Our literature review revealed that unfractionated heparin can potentially antagonize essentially all of the pathophysiological mechanisms known to be activated following SAH. Heparin binds >100 proteins, including plasma proteins, proteins released from platelets, cytokines, and chemokines. Also, heparin complexes with oxyhemoglobin, blocks the activity of free radicals including reactive oxygen species, antagonizes endothelin-mediated vasoconstriction, smooth muscle depolarization, and inflammatory, growth and fibrogenic responses. Our review suggests that the use of prophylactic heparin following SAH may warrant formal study.Keywords
This publication has 146 references indexed in Scilit:
- Neuroinflammation and Memory: The Role of ProstaglandinsMolecular Neurobiology, 2009
- Glutathione peroxidase and subarachnoid hemorrhage: implications for the role of oxidative stress in cerebral vasospasmNeurological Research, 2009
- Neutrophil secretion products pave the way for inflammatory monocytesBlood, 2008
- Membrane‐anchored growth factors, the epidermal growth factor family: Beyond receptor ligandsCancer Science, 2008
- The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subarachnoid HemorrhageNeurocritical Care, 2008
- Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune systemBrain, Behavior, and Immunity, 2007
- Expression and Function of Inwardly Rectifying Potassium Channels after Experimental Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2005
- Time course of production of hydroxyl free radical after subarachnoid hemorrhage in dogsLife Sciences, 2004
- Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhageJournal of Neurosurgery, 1999
- Heparin Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 1992